Regeneron, US75886F1075

Regeneron stock at USD 752.25 on September 28, 2026

Published on 09/28/2026 at 23:47 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS

Regeneron last traded at USD 752.25 on September 28, 2026, down 4.54 percent. The company plans to release third-quarter results on October 30 before U.S. markets open.

Fotorealistisches Biotech-Labor mit Forschern und Pipetten an sterilen ArbeitsplÀtzen
Regeneron Pharma US75886F1075 zeigt ein fotorealistisches Biotech-Labor mit Forschern bei sorgfÀltigen Pipettierarbeiten am sterilen Steriltisch, Illustration mit AI erstellt.

Regeneron Pharmaceuticals, Inc. last traded at USD 752.25 on the Nasdaq on September 28, 2026, according to the latest regular-session quote timestamped 8:00 p.m. UTC. The stock was down 4.54 percent from the previous session’s USD 788.04 close.

Upcoming financial results

Regeneron said on September 24 that it will report its third-quarter 2026 financial and operating results on Friday, October 30, before U.S. financial markets open. The company also scheduled a conference call and simultaneous webcast for 8:30 a.m. Eastern Time that day, according to the GlobeNewswire release issued by Regeneron Pharmaceuticals, Inc.

The webcast will be available through Regeneron’s Investors and Media page. The company said a replay and transcript of the call and webcast will be archived on its website for at least 30 days, the release said.

Disclaimer...

en | US75886F1075 | REGENERON | boerse | 70195753 | bgmi